L'Oreal S.A. header image

L'Oreal S.A.

OR

Equity

ISIN FR0000120321 / Valor 502805

Euronext - Euronext Paris (2024-11-21)
EUR 322.90+0.84%

L'Oreal S.A.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

L'Oreal S.A. is a global cosmetics company with a unique organizational structure that combines strategic concentration with operational decentralization. The company empowers local teams to ensure that they are close and relevant to consumers in every country, creating and producing cosmetics at a local level to meet the specific needs of each market. L'Oreal has a worldwide network of Research & Innovation and marketing hubs in key strategic markets, supported by a global industrial presence to bring innovations to market efficiently. The company's success is driven by its global R&I, diverse portfolio of brands, and integrated industrial production, along with corporate functions such as Administration & Finance, Digital, HR, Communications, and Corporate Responsibility.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Record Sales Growth

L'Oreal S.A. reported record sales of 41.18 billion euros for the year ending December 31, 2023. This represents a +7.6% increase on a reported basis and an impressive +11.0% growth like-for-like. The company achieved this growth despite challenging market conditions, including geopolitical tensions and a stagnating beauty market in China.

Operating Margin Improvement

L'Oreal S.A. continued to improve its operating margin, reaching 19.8% in 2023, an increase of 30 basis points from the previous year. The operating profit for the year was 8,143.3 million euros, showcasing the company's ability to manage costs effectively while driving revenue growth.

Earnings Per Share and Dividend

The earnings per share (EPS) for L'Oreal S.A. in 2023 were 12.08 euros, marking a +7.3% increase from the previous year. The company also announced a dividend of 6.60 euros per share, which is a +10.0% increase, reflecting its strong financial performance and commitment to returning value to shareholders.

Net Cash Flow

L'Oreal S.A. reported a net cash flow of 6.1 billion euros for 2023, up by +23.9% compared to the previous year. This significant increase in cash flow underscores the company's robust financial health and its ability to generate substantial cash from its operations.

Outlook for 2024

Looking ahead to 2024, L'Oreal S.A. remains optimistic about the beauty market's prospects and confident in its ability to continue outperforming the market. The company aims to achieve another year of growth in sales and profits, driven by its focus on Beauty Tech and its multi-polar model, which has proven effective in navigating diverse market conditions.

Summarized from source with an LLMView Source

Key figures

-24.1%1Y
-24.1%3Y
26.4%5Y

Performance

21.7%1Y
24.4%3Y
24.8%5Y

Volatility

Market cap

179374 M

Market cap (USD)

Daily traded volume (Shares)

395,464

Daily traded volume (Shares)

1 day high/low

324.2 / 316.3

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Zoetis Inc
Zoetis Inc Zoetis Inc Valor: 19276994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%USD 176.71
Becton Dickinson & Co.
Becton Dickinson & Co. Becton Dickinson & Co. Valor: 912061
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.38%USD 225.45
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.47%USD 91.50
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.31%USD 66.84
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%USD 295.71
Takeda Yakuhin Kogyo KK
Takeda Yakuhin Kogyo KK Takeda Yakuhin Kogyo KK Valor: 11292411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.30%USD 13.33
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 70.38
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.12%USD 60.35
Cencora Inc
Cencora Inc Cencora Inc Valor: 1212868
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.02%USD 245.69
Resmed Inc
Resmed Inc Resmed Inc Valor: 321632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.85%USD 243.60